- How 2 Common Medications Became One $455 Million Specialty Pill - After I was prescribed a brand-name drug I didn’t need & given a coupon to cover the out-of-pocket costs, I discovered yet another reason why Americans pay too much for health care. https://www.theatlantic.com/health/archive/2017/06/how-two-common-medications-became-one-455-million-specialty-pill/530808/ 8 comments economy
Linking pages
- Do PBMs Delay Drugs and Drive Up Drug Prices? - The Atlantic https://www.theatlantic.com/health/archive/2019/04/pbms-health-care-drug-delays-prices/586711/ 22 comments
- Pay for Delay: Big Pharma’s Most Maddening Business Tactic - The Atlantic https://www.theatlantic.com/ideas/archive/2023/06/pharmaceutical-generic-drugs-pay-for-delay/674410/ 10 comments
- David Mitchell, a Cancer Patient Fighting High Drug Costs - The Atlantic https://www.theatlantic.com/health/archive/2017/09/the-cancer-patient-taking-on-high-drug-prices/538698/ 3 comments
Linked pages
- The Crafty Logic That Accompanies Dementia - The Atlantic https://www.theatlantic.com/health/archive/2023/03/dementia-caregiver-imposter-delusion-paranoia/673308/ 41 comments
- America’s Other Drug Problem — ProPublica https://www.propublica.org/article/americas-other-drug-problem 6 comments
- Dollars for Docs - ProPublica http://projects.propublica.org/docdollars/ 0 comments
- What Hospitals Waste — ProPublica https://www.propublica.org/article/what-hospitals-waste 0 comments
- Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds — ProPublica https://www.propublica.org/article/doctors-who-take-company-cash-tend-to-prescribe-more-brand-name-drugs 0 comments
Related searches:
Search whole site: site:theatlantic.com
Search title: Two Generic Medications Become One Expensive Drug - The Atlantic
See how to search.